TX-001HR

3 Biotechs Awaiting FDA Approval Decisions
Motley Fool
Tue, 10/16/18 - 11:52 am
FDA
TherapeuticsMD
TX-001HR
AcelRx
Dsuvia
Loxo Oncology
larotrectinib